Logo image
Genomic hypomethylation in neoplastic cells from dogs with malignant lymphoproliferative disorders
Journal article   Peer reviewed

Genomic hypomethylation in neoplastic cells from dogs with malignant lymphoproliferative disorders

J.T. Pelham, P.J. Irwin and P.H. Kay
Research in Veterinary Science, Vol.74(1), pp.101-104
2003
url
Link to Published Version *Subscription may be requiredView

Abstract

DNA methylation is an epigenetic modification in which a methyl group is added usually to the fifth carbon position of a cytosine residue. Dysregulation of this process is an important molecular event which has been shown to be associated with neoplastic transformation and tumour progression in humans and mice. Features of methylation dysregulation in many different types of neoplasms include general genomic hypomethylation, focal hypermethylation, and altered expression of genes which encode a series of DNA (cytosine-5) methyltransferases. Interestingly, many types of neoplasia that are recognised in humans also develop spontaneously in the dog. By comparing the restriction patterns of MspI and HpaII, this study demonstrates that as in human, genomic hypomethylation is a feature of neoplastic cells in the majority of canine lymphoma cases and approximately one-third of canine leukemia cases confirming that dysregulation of the DNA methylating machinery is implicated in malignant transformation of lymphoid cells in some dogs.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.54 Molecular & Cell Biology - Genetics
1.54.100 Epigenetic Regulation
Web Of Science research areas
Veterinary Sciences
ESI research areas
Plant & Animal Science
Logo image